Market strategists forecast a ‘great rotation’ into small-capitalization equities in 2026, a shift expected to channel fresh investor capital into high-quality business development companies. Ares Capital, with a diversified portfolio of over 400 middle-market loans spanning industries from healthcare services to software, stands to benefit. The company’s senior secured exposure and historically resilient dividend coverage—four quarters of coverage ratios above 1.1x—position it to capture increased deal flow. As merger and acquisition activity accelerates in a declining-rate environment, Ares Capital’s deal volume is projected to rise by 15% year-over-year, supporting both yield stability and net asset value growth.

Since late 2025, Ares Capital has renegotiated loan spreads on new originations, tightening pricing by approximately 50 basis points on first-lien financings. This shift reflects strong demand for private credit and bolsters the firm’s net interest margin, which rose to 8.2% in Q4 2025 from 7.7% a year earlier. Management estimates this improvement will add roughly $25 million in annualized net investment income, funding potential dividend increases and reducing reliance on fee waivers. With leverage maintained near 1.5x debt-to-equity and liquidity reserves of $2.8 billion, the company is well positioned to capitalize on favorable pricing conditions.

Ares Capital announced its 2025 common stock distributions totaling $1.92 per share, paid in four equal installments of $0.48. Tax reporting indicates 70.65% of the total distributions qualify as ordinary income eligible for the dividends-received deduction, while 29.35% is designated as long-term capital gains. No portion was classified as interest-related dividends. The company’s clear breakdown provides shareholders with precise guidance for 2025 tax filings and underscores consistent cash generation from core lending operations.